Vyne Therapeutics Inc expected to post a loss of $1.99 a share - Earnings Preview

YARROW BIOSCIENCE

08/08/2023 13:58

* Vyne Therapeutics Inc  VYNE.OQ   VYNE.O  is expected
to show a
fall in quarterly revenue when it reports  results on August 10
(estimated). 
    * The Bridgewater New Jersey-based  company is expected to
report 
a 20.6% decrease in revenue to $100 thousand from $126 thousand
a year ago, according to the estimate from one analyst, based on
Refinitiv data. 
    * ​Refinitiv's mean analyst estimate for Vyne Therapeutics
Inc is
for a loss of $1.99 per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 3 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Vyne
Therapeutics
Inc is $72​, above​ its last closing price of $4.71. ​​​

This summary was machine generated August 8 at 12:58 GMT.  All
figures in US dollars  unless otherwise stated